Horw, Switzerland-based CeQur, a medical device company dedicated to simplifying mealtime insulin delivery for individuals, announced that it ...
Vigneshwar Ravichandran
|
January 10, 2025
New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. ...
Business Wire
January 8, 2025
Xinvento is a biotech company focused on developing therapies for congenital hyperinsulinism (CHI).
Vishal Singh
March 2, 2023
Europe’s startup ecosystem has grown over the past decade, with several companies reaching the billion-dollar mark. Atomico’s State ...
April 2, 2025
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, ...
March 18, 2025
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology ...
Improvements in fibrosis observed using 3 pre-specified methods of histological analysis: conventional, AIM-MASH (PathAI) and qFibrosis (Histoindex) Mechanistically, ...
March 6, 2025
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Italy, Denmark, Finland, Norway, and Sweden ...
January 13, 2025
Ascensia has created a virtual wellness zone to answer questions aligning to the IDF’s 2024 theme of ‘Diabetes ...
November 14, 2024
Dexcom EASD Symposium brings together expert panellists from across Europe to explore the transformational effects of Dexcom CGM ...
September 4, 2024
The world’s most connected continuous glucose monitoring system‡, Dexcom G6, now connects with the Omnipod® 5 Automated Insulin ...
June 20, 2024
Omnipod 5, the world’s first tubeless automated insulin delivery (AID) system integrated with Dexcom G6, is now available ...
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
Celebrating 20 years of driving ‘High-Tech’ innovation: Berlin to host HTGF Family Day 2025; 4 reasons to join